EUClinicalTrials.govClinical trialNot applicableRecruiting
Butyrophilins Role in Colon Cancer
Official record
- Identifier
NCT04185272- Recruiting locations
country
France- Interventions studied
- analysis of BTN and BTNL status
- Lead sponsor
- Institut Paoli-Calmettes
- Target enrolment
- 200 participants
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Status
- Recruiting
- First posted
- Dec 4, 2019
- Last updated on the registry
- Oct 1, 2026
- Age
- 18 Years
- Sex
- ALL
- Study contact
- The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: * Patient is older than 18 years old, * Signed participation consent, * Non-metastatic colon cancer immediately resectable or metastatic and liver synchronous for which it was decided a combined colic and liver surgery (metastatic patient at the outset) in multidisciplinary consultation meeting. * Performance Status (PS) 0 or 1 * affiliated to the social security or beneficiary Exclusion Criteria: * Rectal cancer, colon cancer recurrence * Emergency of colon cancer Surgery * History of inflammatory disease of the digestive tract (Crohn's disease or ulcerative colitis) * Patient who received neoadjuvant therapy other than chemotherapy * Patient treated with immune-suppressors or long-course corticosteroids \<12 months * Pregnant women or likely to be pregnant (without effective contraception) or breastfeeding, * Person in urgent situation, person under legal protection measure, or unable to express his / her consent, * Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons
- Indexed under
- Colorectal Cancer